恩曲他滨/替诺福韦 (Chinese Wikipedia)

World Health Organization. Stuart MC, Kouimtzi M, Hill SR , 编. WHO Model Formulary 2008. World Health Organization. 2009: 160. ISBN 9789241547659. hdl:10665/44053.
World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

healthaffairs.org (Global: low place; Chinese: low place)

Keith, Katie. New Guidance On PrEP: Support Services Must Be Covered Without Cost-Sharing | Health Affairs Forefront. Health Affairs Forefront. 2021 [2022-08-04]. doi:10.1377/forefront.20210728.333084 （英语）.

irishtimes.com (Global: 252^nd place; Chinese: 912^th place)

Gilead loss of generic HIV drug battle a boost for gay community. The Irish Times. [2018-05-18]. （原始内容存档于2018-05-18）.
Gilead in row with generics manufacturers over HIV drug in Ireland. The Irish Times. [2017-10-30]. （原始内容存档于2017-11-07）.

iwantprepnow.co.uk (Global: low place; Chinese: low place)

Free PrEP on the NHS.

medicalxpress.com (Global: low place; Chinese: low place)

EU door opens for generic version of AIDS medicine Truvada. [2024-08-09]. （原始内容存档于2023-12-04）.

medicines.org.uk (Global: 4,892^nd place; Chinese: 1,886^th place)

UK label Truvada film-coated tablets. Electronic Medicines Compendium. August 2016. （原始内容存档于2016-12-20）.

nice.org.uk (Global: 4,081^st place; Chinese: 2,945^th place)

Pre-exposure prophylaxis of HIV in adults at high risk: Truvada (emtricitabine/tenofovir disoproxil). 2016-10-05 [2024-08-09]. （原始内容存档于2019-11-02）.

nih.gov (Global: 5^th place; Chinese: 3^rd place)

ncbi.nlm.nih.gov

Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012, 7 (7): CD007189. PMID 22786505. S2CID 35672491. doi:10.1002/14651858.CD007189.pub3.
Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, Grusing S, Korthuis PT. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019-06-11, 321 (22): 2214–2230. ISSN 0098-7484. PMID 31184746. S2CID 184485546. doi:10.1001/jama.2019.2591 .
Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis (PDF). MMWR Recomm Rep. September 2005, 54 (RR-9): 1–17 [2024-08-09]. PMID 16195697. （原始内容存档 (PDF)于2020-07-31）.
Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis (PDF). Infection Control and Hospital Epidemiology. September 2013, 34 (9): 875–92 [2024-08-09]. PMID 23917901. S2CID 17032413. doi:10.1086/672271. 20711. （原始内容存档 (PDF)于2019-10-30）. 本条目含有公有领域來源内容。
Tenofovir. Drugs and Lactation Database (LactMed) (National Library of Medicine (US)). 2006 [2019-10-23]. PMID 30000609. （原始内容存档于2021-02-26）.
Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM. Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine. Clin. Infect. Dis. July 2018, 67 (3): 411–419. PMC 6051460 . PMID 29415175. doi:10.1093/cid/ciy083. * Template:Lay source
Ramanathan S, Shen G, Cheng A, Kearney BP. Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. J. Acquir. Immune Defic. Syndr. July 2007, 45 (3): 274–9. PMID 17414929. S2CID 31756102. doi:10.1097/QAI.0b013e318050d88c .

aidsinfo.nih.gov

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (PDF). AIDSinfo Clinical Guidelines. July 2019 [2019-10-30]. （原始内容 (PDF)存档于2016-12-04）.
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (PDF). [2019-10-30]. （原始内容 (PDF)存档于2016-12-02-04）.
Brief What's New in the Guidelines Perinatal. AIDSinfo. [2019-10-23]. （原始内容存档于2019-10-23）.
Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States (PDF). National Institutes of Health (NIH). [2014-10-21]. （原始内容存档 (PDF)于2014-04-12）.

dailymed.nlm.nih.gov

Truvada- emtricitabine and tenofovir disoproxil fumarate tablet, film coated label. DailyMed. 2018-05-18 [2019-10-31]. （原始内容存档于2019-10-31）.
DailyMed - XENICAL- orlistat capsule. dailymed.nlm.nih.gov. [2019-10-30]. （原始内容存档于2019-02-27）.

nwsource.com (Global: 1,828^th place; Chinese: 1,474^th place)

seattletimes.nwsource.com

Perrone, Matthew. FDA approves first pill to help prevent HIV. The Seattle Times. Associated Press. 2012-07-16. （原始内容存档于2012-07-19）.

pharmacy-xl.org (Global: low place; Chinese: low place)

Generic Sovaldi. [2024-08-09]. （原始内容存档于2024-07-16）.

pharmaphorum.com (Global: low place; Chinese: low place)

Truvada ruling could allow cheap HIV prevention in the UK -. 2018-09-19 [2024-08-09]. （原始内容存档于2024-04-21）.

reuters.com (Global: 38^th place; Chinese: 61^st place)

Blake Brittain. Gilead Sciences prevails in US government lawsuit over HIV drug patents. Reuter. 2023-05-10 [2024-0724]. （原始内容存档于2023-05-20）.

semanticscholar.org (Global: 15^th place; Chinese: 141^st place)

api.semanticscholar.org

Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012, 7 (7): CD007189. PMID 22786505. S2CID 35672491. doi:10.1002/14651858.CD007189.pub3.
Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, Grusing S, Korthuis PT. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019-06-11, 321 (22): 2214–2230. ISSN 0098-7484. PMID 31184746. S2CID 184485546. doi:10.1001/jama.2019.2591 .
Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis (PDF). Infection Control and Hospital Epidemiology. September 2013, 34 (9): 875–92 [2024-08-09]. PMID 23917901. S2CID 17032413. doi:10.1086/672271. 20711. （原始内容存档 (PDF)于2019-10-30）. 本条目含有公有领域來源内容。
Ramanathan S, Shen G, Cheng A, Kearney BP. Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. J. Acquir. Immune Defic. Syndr. July 2007, 45 (3): 274–9. PMID 17414929. S2CID 31756102. doi:10.1097/QAI.0b013e318050d88c .

statnews.com (Global: 7,413^th place; Chinese: 6,376^th place)

Silverman, Ed. Biden administration appeals jury finding in battle over patents for HIV prevention pills. STAT News. 2024-07-08 [2024-07-08]. （原始内容存档于2024-08-02）.

tga.gov.au (Global: 4,353^rd place; Chinese: 1,620^th place)

Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017. Therapeutic Goods Administration (TGA). 2022-06-21 [2024-03-30]. （原始内容存档于2023-07-06）.

uptodate.com (Global: 4,645^th place; Chinese: 2,579^th place)

Administration of pre-exposure prophylaxis against HIV infection. UpToDate. [2019-10-31]. （原始内容存档于2019-11-01）.

washingtonpost.com (Global: 35^th place; Chinese: 84^th place)

Rowland, Christopher. Gilead defied a government HIV patent. The Justice Department has opened a review.. The Washington Post. 2019-04-24 [2019-10-31]. （原始内容存档于2019-11-01）.
Rowland, Christopher. Gilead files challenge to government patents for HIV prevention pill. The Washington Post. 2019-08-21 [2019-10-29]. （原始内容存档于2019-11-01）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Emtricitabine / tenofovir Pregnancy and Breastfeeding Warnings. Drugs.com. 2018-08-01 [2019-10-10]. （原始内容存档于2019-10-10）.
Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017. Therapeutic Goods Administration (TGA). 2022-06-21 [2024-03-30]. （原始内容存档于2023-07-06）.
Truvada EPAR. European Medicines Agency. 2005-02-21 [2024-06-13]. （原始内容存档于2024-05-12）.
Truvada. Drugs.com. [2016-12-12]. （原始内容存档于2016-12-20）.
UK label Truvada film-coated tablets. Electronic Medicines Compendium. August 2016. （原始内容存档于2016-12-20）.
Truvada- emtricitabine and tenofovir disoproxil fumarate tablet, film coated label. DailyMed. 2018-05-18 [2019-10-31]. （原始内容存档于2019-10-31）.
The Top 300 of 2020. ClinCalc. [2022-10-07]. （原始内容存档于2020-03-18）.
Emtricitabine; Tenofovir Disoproxil - Drug Usage Statistics. ClinCalc. [2022-10-07]. （原始内容存档于2023-10-04）.
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (PDF). AIDSinfo Clinical Guidelines. July 2019 [2019-10-30]. （原始内容 (PDF)存档于2016-12-04）.
PrEP. Centers for Disease Control and Prevention (CDC). 2019-10-17 [2019-10-31]. （原始内容存档于2019-10-31）. 本条目含有公有领域來源内容。
Perrone, Matthew. FDA approves first pill to help prevent HIV. The Seattle Times. Associated Press. 2012-07-16. （原始内容存档于2012-07-19）.
Pre-Exposure Prophylaxis (PrEP). [2015-06-04]. （原始内容存档于2015-06-05）. 本条目含有公有领域來源内容。
Administration of pre-exposure prophylaxis against HIV infection. UpToDate. [2019-10-31]. （原始内容存档于2019-11-01）.
Pre-exposure prophylaxis of HIV in adults at high risk: Truvada (emtricitabine/tenofovir disoproxil). 2016-10-05 [2024-08-09]. （原始内容存档于2019-11-02）.
Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis (PDF). MMWR Recomm Rep. September 2005, 54 (RR-9): 1–17 [2024-08-09]. PMID 16195697. （原始内容存档 (PDF)于2020-07-31）.
Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis (PDF). Infection Control and Hospital Epidemiology. September 2013, 34 (9): 875–92 [2024-08-09]. PMID 23917901. S2CID 17032413. doi:10.1086/672271. 20711. （原始内容存档 (PDF)于2019-10-30）. 本条目含有公有领域來源内容。
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (PDF). [2019-10-30]. （原始内容 (PDF)存档于2016-12-02-04）.
Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance (PDF). [2019-11-20]. （原始内容 (PDF)存档于2020-01-25）.
Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance (PDF). [2019-11-20]. （原始内容 (PDF)存档于2020-01-25）.
Brief What's New in the Guidelines Perinatal. AIDSinfo. [2019-10-23]. （原始内容存档于2019-10-23）.
Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States (PDF). National Institutes of Health (NIH). [2014-10-21]. （原始内容存档 (PDF)于2014-04-12）.
Emtricitabine / tenofovir Use During Pregnancy. Drugs.com. [2019 -10-23]. （原始内容存档于2019-10-10）.
Tenofovir. Drugs and Lactation Database (LactMed) (National Library of Medicine (US)). 2006 [2019-10-23]. PMID 30000609. （原始内容存档于2021-02-26）.
PrEP does not raise lipids or alter body fat, safety study finds. [2018-02-16]. （原始内容存档于2018-02-17）.
DailyMed - XENICAL- orlistat capsule. dailymed.nlm.nih.gov. [2019-10-30]. （原始内容存档于2019-02-27）.
EP0915894B1 - NUCLEOTIDE ANALOGS. Espacenet. [2017-12-13]. （原始内容存档于2019-01-30）.
U.K. Court invalidates Gilead's Truvada patent extension, allowing PrEP generics. 2018-09-19 [2024-08-09]. （原始内容存档于2023-12-06）.
Truvada ruling could allow cheap HIV prevention in the UK -. 2018-09-19 [2024-08-09]. （原始内容存档于2024-04-21）.
EU door opens for generic version of AIDS medicine Truvada. [2024-08-09]. （原始内容存档于2023-12-04）.
Gilead loss of generic HIV drug battle a boost for gay community. The Irish Times. [2018-05-18]. （原始内容存档于2018-05-18）.
Gilead in row with generics manufacturers over HIV drug in Ireland. The Irish Times. [2017-10-30]. （原始内容存档于2017-11-07）.
European PrEP programs face two big issues: How to get more people coming forward, and how to serve them if they do. 2021-01-27 [2024-08-09]. （原始内容存档于2024-08-18）.
Rowland, Christopher. Gilead defied a government HIV patent. The Justice Department has opened a review.. The Washington Post. 2019-04-24 [2019-10-31]. （原始内容存档于2019-11-01）.
Rowland, Christopher. Gilead files challenge to government patents for HIV prevention pill. The Washington Post. 2019-08-21 [2019-10-29]. （原始内容存档于2019-11-01）.
Petitions to US Patent and Trademark Office on HIV PrEP Patents. Gilead Sciences (新闻稿). 2019-08-21 [2019-10-29]. （原始内容存档于2019-10-30）.
Blake Brittain. Gilead Sciences prevails in US government lawsuit over HIV drug patents. Reuter. 2023-05-10 [2024-0724]. （原始内容存档于2023-05-20）.
Silverman, Ed. Biden administration appeals jury finding in battle over patents for HIV prevention pills. STAT News. 2024-07-08 [2024-07-08]. （原始内容存档于2024-08-02）.
HIV drug PrEP to be available across England. [2024-08-09]. （原始内容存档于2024-04-10）.
Generic Sovaldi. [2024-08-09]. （原始内容存档于2024-07-16）.

worldcat.org (Global: 4^th place; Chinese: 4^th place)

Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, Grusing S, Korthuis PT. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019-06-11, 321 (22): 2214–2230. ISSN 0098-7484. PMID 31184746. S2CID 184485546. doi:10.1001/jama.2019.2591 .

恩曲他滨/替诺福韦 (Chinese Wikipedia)

aasld.org (Global: low place; Chinese: low place)

aidsmap.com (Global: low place; Chinese: low place)

archive.org (Global: 6th place; Chinese: 2nd place)

cdc.gov (Global: 251st place; Chinese: 220th place)

cdc.gov

stacks.cdc.gov

clincalc.com (Global: 5,833rd place; Chinese: 2,124th place)

cms.gov (Global: low place; Chinese: low place)

doi.org (Global: 2nd place; Chinese: 5th place)

drugs.com (Global: 529th place; Chinese: 229th place)

espacenet.com (Global: 950th place; Chinese: 938th place)

worldwide.espacenet.com

europa.eu (Global: 62nd place; Chinese: 150th place)

ema.europa.eu

fiercepharma.com (Global: low place; Chinese: low place)

gilead.com (Global: low place; Chinese: low place)

gov.uk (Global: 401st place; Chinese: 528th place)

hdl.handle.net (Global: 66th place; Chinese: 243rd place)

healthaffairs.org (Global: low place; Chinese: low place)

irishtimes.com (Global: 252nd place; Chinese: 912th place)

iwantprepnow.co.uk (Global: low place; Chinese: low place)

medicalxpress.com (Global: low place; Chinese: low place)

medicines.org.uk (Global: 4,892nd place; Chinese: 1,886th place)

nice.org.uk (Global: 4,081st place; Chinese: 2,945th place)

nih.gov (Global: 5th place; Chinese: 3rd place)

ncbi.nlm.nih.gov

aidsinfo.nih.gov

dailymed.nlm.nih.gov

nwsource.com (Global: 1,828th place; Chinese: 1,474th place)

seattletimes.nwsource.com

pharmacy-xl.org (Global: low place; Chinese: low place)

pharmaphorum.com (Global: low place; Chinese: low place)

reuters.com (Global: 38th place; Chinese: 61st place)

semanticscholar.org (Global: 15th place; Chinese: 141st place)

api.semanticscholar.org

statnews.com (Global: 7,413th place; Chinese: 6,376th place)

tga.gov.au (Global: 4,353rd place; Chinese: 1,620th place)

uptodate.com (Global: 4,645th place; Chinese: 2,579th place)

washingtonpost.com (Global: 35th place; Chinese: 84th place)

web.archive.org (Global: 1st place; Chinese: 1st place)

worldcat.org (Global: 4th place; Chinese: 4th place)

archive.org (Global: 6^th place; Chinese: 2^nd place)

cdc.gov (Global: 251^st place; Chinese: 220^th place)

clincalc.com (Global: 5,833^rd place; Chinese: 2,124^th place)

doi.org (Global: 2^nd place; Chinese: 5^th place)

drugs.com (Global: 529^th place; Chinese: 229^th place)

espacenet.com (Global: 950^th place; Chinese: 938^th place)

europa.eu (Global: 62^nd place; Chinese: 150^th place)

gov.uk (Global: 401^st place; Chinese: 528^th place)

hdl.handle.net (Global: 66^th place; Chinese: 243^rd place)

irishtimes.com (Global: 252^nd place; Chinese: 912^th place)

medicines.org.uk (Global: 4,892^nd place; Chinese: 1,886^th place)

nice.org.uk (Global: 4,081^st place; Chinese: 2,945^th place)

nih.gov (Global: 5^th place; Chinese: 3^rd place)

nwsource.com (Global: 1,828^th place; Chinese: 1,474^th place)

reuters.com (Global: 38^th place; Chinese: 61^st place)

semanticscholar.org (Global: 15^th place; Chinese: 141^st place)

statnews.com (Global: 7,413^th place; Chinese: 6,376^th place)

tga.gov.au (Global: 4,353^rd place; Chinese: 1,620^th place)

uptodate.com (Global: 4,645^th place; Chinese: 2,579^th place)

washingtonpost.com (Global: 35^th place; Chinese: 84^th place)

web.archive.org (Global: 1^st place; Chinese: 1^st place)

worldcat.org (Global: 4^th place; Chinese: 4^th place)